Partner Roger Strode was quoted in a Modern Healthcare article, “Will Prime’s M&A Momentum Be Stalled By Federal Lawsuit,” on May 28, 2016. The article discussed the federal allegations that Prime Healthcare Services’ turnaround strategy is to drive up revenue by pushing doctors to admit more patients. Strode said the government’s involvement may raise questions among hospital boards looking to do business with Prime. He was quoted saying, “If it’s going to be a choice and they get down to a situation where there are two or three active bidders, I can’t imagine it doesn’t at least weight into their thinking. If you’re Prime, you’re going to have to do some explaining.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”